Where it trades today
trading 62% of the way up its 52-week range
How the price has moved
What to weigh before acting
What Matters Now
- Order-book quality, backlog conversion, and operating leverage usually tell you more than a single quarter of revenue growth.
- EMR trades at 32.8x earnings, well above the industrials average of 18.5x, so the market is already pricing in above-consensus execution.
- EMR carries a beta of 1.23, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- Relative performance versus CAT, HON matters here because leadership inside industrials rarely stays static for long.
Portfolio Use Case
- EMR is more useful for investors comparing conviction names inside industrials than for someone looking for a passive “set and forget” holding.
- This name works better as a satellite or higher-conviction growth position because it can amplify market swings in both directions.
- This page is most useful for deciding whether the stock deserves a permanent slot in the portfolio or just a place on the watchlist.
What Would Change the View
- A reset in earnings expectations or a faster peer catch-up could compress the premium valuation currently embedded in EMR.
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
- The view would need revisiting if peers such as CAT, HON start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for EMR come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Industrials so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as CAT, HON.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for EMR. Last refresh: Sep 18, 2026, 10:56 PM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as CAT, HON.
What Emerson Electric does
Emerson Electric Co., a technology and software company, provides various solutions in the Americas, Asia, the Middle East, Africa, and Europe. It operates through Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, and Test & Measurement segments. The Final Control segment provides control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries under Anderson Greenwood, Bettis, Crosby, Fisher, Keystone, KTM, and Vanessa brands. The Measurement & Analytical segment supplies intelligent instrumentation measuring the physical properties of…
Employees
71,000
Industry
Specialty Industrial Machinery
Headquarters
Saint Louis, United States
What analysts expect
EMR carries a buy consensus from 27 analysts, with an average price target of $172.63 versus $149.92 today (+15.1%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
EMR generated $18.64B in trailing revenue (7.0% year over year), with a 13.8% net margin, and $3.71B of free cash flow, against $11.62B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $18.02B | $9.52B | $3.53B | $2.29B | $4.07 | $2.67B |
| 2024 | $17.49B | $8.88B | $2.67B | $1.97B | $3.45 | $2.91B |
| 2023 | $15.16B | $7.43B | $2.76B | $13.22B | $23.11 | $274.00M |
| 2022 | $13.80B | $6.31B | $2.36B | $3.23B | $5.46 | $2.62B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
How it sits in industrials
Manufacturing, aerospace, defense, and infrastructure companies.
The companies it competes with
EMR beside the industrials names it is usually measured against.
What the chart is saying
Emerson Electric trades at $149.92, 9.9% below its 52-week high. With a beta of 1.23, it shows more sensitivity to what the wider market does.
Questions people ask about it
Is EMR a good buy right now?
Emerson Electric trades at 32.8x earnings. This is above market average, reflecting growth expectations. Current risk level is Medium based on 25.0% volatility.
Does EMR pay dividends?
Yes, Emerson Electric offers a dividend yield of 1.51%. That is roughly $2.26 per share a year.
How volatile is EMR?
With 30-day annualized volatility of 25.0% and beta of 1.23, EMR is classified as Medium risk. Expect larger swings than the broader market during volatile periods.
What is the analyst price target for EMR?
The average analyst price target for Emerson Electric (EMR) is $172.63 based on 27 analyst estimates, about 15.1% above the current price of $149.92. The published range runs from $104.00 to $205.00.
How much revenue does EMR generate?
Emerson Electric reported $18.64B in trailing twelve-month revenue. Revenue growth is running at 7.0% year over year. Net margin sits at 13.8%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.